"use client";
import React from 'react';
import Image from 'next/image';
import { Icon } from './common.jsx';
const START_URL = "https://go.telehealthfx.com/start";

function BlogBariatricVsGLP1() {
  return (<><section className="section" style={{ minHeight: '60vh', paddingTop: 120 }}><div className="container" style={{ maxWidth: 800 }}>
    <div className="eyebrow" style={{ marginBottom: 20 }}>Surgery vs. Medication</div>
    <h1 className="serif" style={{ fontSize: 52, marginBottom: 24, lineHeight: 1.08 }}>Bariatric Surgery vs. GLP-1: <span style={{ fontStyle: 'italic', color: 'var(--brand)' }}>Which Produces Better Long-Term Results? (Cost, Risk &amp; Outcome Data)</span></h1>
    <div style={{ display: 'flex', alignItems: 'center', gap: 12, marginBottom: 48, paddingBottom: 24, borderBottom: '1px solid var(--line-soft)' }}><div style={{ width: 40, height: 40, borderRadius: '50%', background: 'var(--brand)' }}><Image src="/assets/jm-profile.jpg" alt="Julian Mercer" width={1024} height={1024} style={{ width: '100%', height: '100%', objectFit: 'cover', borderRadius: '50%', height: "auto"}} priority={true} /></div><div><div style={{ fontWeight: 500, fontSize: 14 }}><a href="/about" style={{ color: "var(--ink)", textDecoration: "none" }}>Julian Mercer, M.S.</a></div><div style={{ fontSize: 13, color: 'var(--ink-3)' }}>Lead Bio-Systems Analyst · Updated May 2026 · 20 min read</div></div></div>
    <div className="blog-content" style={{ fontSize: 18, lineHeight: 1.7, color: 'var(--ink-2)' }}>
      <Image src="/assets/bariatric-surgery-vs-glp1-featured.png" alt="Operating room vs home injection comparison" width={1024} height={1024} style={{ width: '100%', borderRadius: 16, marginBottom: 40, border: '1px solid var(--line-soft)', height: "auto"}} priority={true} />
      <p>For decades, bariatric surgery was the only proven intervention for severe obesity producing more than 20% sustained weight loss. GLP-1 medications are now closing that gap — tirzepatide{"'"}s 22.5% weight loss in SURMOUNT-1 approaches the 25–30% seen with gastric sleeve. But this is not just about pounds lost. It is about risk, reversibility, lifestyle impact, cost, and long-term sustainability. Here is the honest, complete comparison.</p>

      <h2 className="serif" style={{ fontSize: 32, marginTop: 48, marginBottom: 24, color: 'var(--ink)' }}>The Complete Head-to-Head Comparison</h2>
      <div style={{ overflowX: 'auto', margin: '24px 0' }}>
        <table style={{ width: '100%', borderCollapse: 'collapse', fontSize: 15 }}>
          <thead><tr style={{ borderBottom: '2px solid var(--ink)' }}><th style={{ textAlign: 'left', padding: '12px 16px', fontWeight: 600 }}>Factor</th><th style={{ textAlign: 'left', padding: '12px 16px', fontWeight: 600 }}>Gastric Sleeve (VSG)</th><th style={{ textAlign: 'left', padding: '12px 16px', fontWeight: 600 }}>Gastric Bypass (RYGB)</th><th style={{ textAlign: 'left', padding: '12px 16px', fontWeight: 600 }}>GLP-1 Medication</th></tr></thead>
          <tbody>
            <tr style={{ borderBottom: '1px solid var(--line-soft)' }}><td style={{ padding: '12px 16px', fontWeight: 500 }}>Avg weight loss</td><td style={{ padding: '12px 16px', fontWeight: 600 }}>25–30%</td><td style={{ padding: '12px 16px', fontWeight: 600 }}>30–35%</td><td style={{ padding: '12px 16px' }}>15–22.5%</td></tr>
            <tr style={{ borderBottom: '1px solid var(--line-soft)' }}><td style={{ padding: '12px 16px', fontWeight: 500 }}>Upfront cost</td><td style={{ padding: '12px 16px', color: '#DC2626' }}>$15,000–$25,000</td><td style={{ padding: '12px 16px', color: '#DC2626' }}>$20,000–$35,000</td><td style={{ padding: '12px 16px', color: 'green', fontWeight: 600 }}>$0 (month-to-month)</td></tr>
            <tr style={{ borderBottom: '1px solid var(--line-soft)' }}><td style={{ padding: '12px 16px', fontWeight: 500 }}>Monthly cost</td><td style={{ padding: '12px 16px' }}>$0 (one-time)</td><td style={{ padding: '12px 16px' }}>$0 (one-time)</td><td style={{ padding: '12px 16px' }}><a href="/blog/semaglutide-real-cost-2026" style={{ color: 'var(--brand)' }}>$199–$499</a></td></tr>
            <tr style={{ borderBottom: '1px solid var(--line-soft)' }}><td style={{ padding: '12px 16px', fontWeight: 500 }}>Reversible</td><td style={{ padding: '12px 16px', color: '#DC2626' }}>No (permanent)</td><td style={{ padding: '12px 16px', color: '#DC2626' }}>No (permanent)</td><td style={{ padding: '12px 16px', color: 'green', fontWeight: 600 }}>Yes (stop anytime)</td></tr>
            <tr style={{ borderBottom: '1px solid var(--line-soft)' }}><td style={{ padding: '12px 16px', fontWeight: 500 }}>Recovery time</td><td style={{ padding: '12px 16px' }}>4–6 weeks</td><td style={{ padding: '12px 16px' }}>6–8 weeks</td><td style={{ padding: '12px 16px', color: 'green', fontWeight: 600 }}>None</td></tr>
            <tr style={{ borderBottom: '1px solid var(--line-soft)' }}><td style={{ padding: '12px 16px', fontWeight: 500 }}>Surgical complications</td><td style={{ padding: '12px 16px' }}>10–15%</td><td style={{ padding: '12px 16px' }}>15–20%</td><td style={{ padding: '12px 16px', color: 'green' }}>N/A (no surgery)</td></tr>
            <tr style={{ borderBottom: '1px solid var(--line-soft)' }}><td style={{ padding: '12px 16px', fontWeight: 500 }}>Mortality risk</td><td style={{ padding: '12px 16px' }}>0.03–0.1%</td><td style={{ padding: '12px 16px' }}>0.1–0.3%</td><td style={{ padding: '12px 16px', color: 'green' }}>None</td></tr>
            <tr style={{ borderBottom: '1px solid var(--line-soft)' }}><td style={{ padding: '12px 16px', fontWeight: 500 }}>Nutritional deficiency</td><td style={{ padding: '12px 16px' }}>Moderate risk</td><td style={{ padding: '12px 16px', color: '#DC2626' }}>High risk (lifelong supplements)</td><td style={{ padding: '12px 16px', color: 'green' }}>Minimal</td></tr>
            <tr><td style={{ padding: '12px 16px', fontWeight: 500 }}>10-year regain rate</td><td style={{ padding: '12px 16px' }}>20–30%</td><td style={{ padding: '12px 16px' }}>15–25%</td><td style={{ padding: '12px 16px' }}>Ongoing treatment <a href="/blog/glp1-weight-regain-prevention-2026" style={{ color: 'var(--brand)' }}>prevents regain</a></td></tr>
          </tbody>
        </table>
      </div>

      <h2 className="serif" style={{ fontSize: 32, marginTop: 48, marginBottom: 24, color: 'var(--ink)' }}>When Surgery May Be the Better Choice</h2>
      <p>We are not anti-surgery. For certain patients, bariatric surgery remains the strongest intervention:</p>
      <ul>
        <li style={{ marginBottom: 12 }}><strong>BMI 40+ (class III obesity):</strong> The absolute weight loss from surgery — often 80–120+ lbs — may be necessary for patients with very high starting weight, particularly when mobility is severely limited.</li>
        <li style={{ marginBottom: 12 }}><strong>BMI 35+ with severe comorbidities:</strong> Patients with uncontrolled type 2 diabetes, heart failure, or severe OSA who need maximum weight loss in a shorter timeframe may benefit from the surgical approach.</li>
        <li style={{ marginBottom: 12 }}><strong>Failed GLP-1 therapy:</strong> Some patients do not respond adequately to GLP-1 medications. Surgery becomes a reasonable next step after pharmaceutical options are explored.</li>
        <li style={{ marginBottom: 12 }}><strong>Patient preference:</strong> Some patients prefer a one-time intervention over ongoing medication, understanding the tradeoffs.</li>
      </ul>

      <h2 className="serif" style={{ fontSize: 32, marginTop: 48, marginBottom: 24, color: 'var(--ink)' }}>When GLP-1 Is the Smarter First Step</h2>
      <p>For the majority of patients — particularly those with BMI 27–40 — GLP-1 offers comparable metabolic outcomes with dramatically lower risk:</p>
      <ul>
        <li style={{ marginBottom: 12 }}><strong>No surgical risk.</strong> Zero mortality risk, no anesthesia, no infection, no leaks, no hospital stay. Side effects are limited to GI symptoms that typically resolve. See our <a href="/blog/glp-1-side-effects-how-to-manage-nausea-fatigue-mo" style={{ color: 'var(--brand)', fontWeight: 500 }}>side effects guide</a>.</li>
        <li style={{ marginBottom: 12 }}><strong>Fully reversible.</strong> You can stop GLP-1 anytime. Surgery permanently alters your anatomy. If you do not like the results, your options are limited.</li>
        <li style={{ marginBottom: 12 }}><strong>No recovery period.</strong> Surgery requires 4–8 weeks off work. GLP-1 requires zero downtime — you start during a telehealth visit and receive your medication by mail.</li>
        <li style={{ marginBottom: 12 }}><strong>Cardiovascular benefit proven.</strong> The <a href="/blog/glp-1-and-your-heart-the-select-trial-cardiovascul" style={{ color: 'var(--brand)', fontWeight: 500 }}>SELECT trial</a> proved semaglutide reduces MACE events by 20%. Surgery has observational cardiovascular data but no randomized controlled trial of this caliber.</li>
        <li style={{ marginBottom: 12 }}><strong>Lower total cost at 1–3 years.</strong> At $199–$499/month, GLP-1 costs $2,388–$5,988/year. Surgery costs $15,000–$35,000 upfront plus potential revision costs. Breakeven is 3–7 years. <a href="/blog/hsa-fsa-glp-1-2026" style={{ color: 'var(--brand)', fontWeight: 500 }}>HSA/FSA</a> accepted.</li>
      </ul>

      <div className="card" style={{ padding: 40, margin: '48px 0', textAlign: 'center', background: '#FFFDF9', borderColor: 'var(--brand)' }}>
        <h3 className="serif" style={{ fontSize: 28, marginBottom: 16, color: 'var(--ink)' }}>Try Medication Before Surgery.</h3>
        <p style={{ marginBottom: 24, fontSize: 16 }}>Reversible. No downtime. No surgical risk. $199/month vs. $25,000. If it works — you never need surgery. If it does not — surgery remains an option.</p>
        <a href={START_URL} target="_blank" rel="noopener noreferrer" className="btn btn-primary btn-lg" style={{ display: 'inline-flex', justifyContent: 'center' }}>Start Your Evaluation <Icon.Arrow /></a>
      </div>

      <h2 className="serif" style={{ fontSize: 32, marginTop: 48, marginBottom: 24, color: 'var(--ink)' }}>GLP-1 After Bariatric Surgery</h2>
      <p>An increasingly common scenario: patients who had bariatric surgery years ago and experienced partial weight regain. GLP-1 medication can serve as a powerful adjunct. We cover this in detail in our <a href="/blog/glp1-after-bariatric-surgery-2026" style={{ color: 'var(--brand)', fontWeight: 500 }}>post-bariatric GLP-1 guide</a>. The short version: semaglutide and tirzepatide are safe and effective after bariatric surgery, typically producing an additional 10–15% weight loss from the regained weight.</p>

      <h2 className="serif" style={{ fontSize: 32, marginTop: 48, marginBottom: 24, color: 'var(--ink)' }}>Frequently Asked Questions</h2>
      <h4 style={{ fontSize: 20, marginTop: 24, marginBottom: 8, color: 'var(--ink)' }}>My surgeon says I need surgery. Should I try GLP-1 first?</h4>
      <p style={{ marginBottom: 24 }}>Many obesity medicine specialists now recommend trying GLP-1 medication before surgery, especially for BMI 30–40. GLP-1 has zero surgical risk, is fully reversible, and produces comparable metabolic improvements. If GLP-1 achieves your goals, surgery becomes unnecessary.</p>
      <h4 style={{ fontSize: 20, marginTop: 24, marginBottom: 8, color: 'var(--ink)' }}>Does insurance cover GLP-1 as an alternative to surgery?</h4>
      <p style={{ marginBottom: 24 }}>Some insurers are beginning to cover GLP-1 for weight loss, though coverage varies widely. See our <a href="/blog/insurance-coverage-glp1-2026" style={{ color: 'var(--brand)', fontWeight: 500 }}>insurance coverage guide</a>. Compounded GLP-1 at $199/month does not require insurance.</p>
      <h4 style={{ fontSize: 20, marginTop: 24, marginBottom: 8, color: 'var(--ink)' }}>Can I take GLP-1 AND have surgery?</h4>
      <p style={{ marginBottom: 24 }}>Some surgeons now prescribe GLP-1 before surgery to reduce liver size and operative risk, and after surgery to prevent regain. This combination approach is emerging as best practice for complex cases.</p>

      <div style={{ padding: 40, marginTop: 60, borderRadius: 20, background: 'var(--ink)', color: '#FBF8F3', textAlign: 'center' }}>
        <h2 className="serif" style={{ fontSize: 40, marginBottom: 20, color: '#FBF8F3' }}>Same Results. No Scalpel.</h2>
        <p style={{ fontSize: 18, opacity: 0.9, marginBottom: 32, maxWidth: 500, margin: '0 auto 32px' }}>Compounded semaglutide from $199/mo. Tirzepatide from $349/mo. Reversible. Month-to-month. Clinician-guided.</p>
        <a href={START_URL} target="_blank" rel="noopener noreferrer" className="btn btn-lg" style={{ background: '#FBF8F3', color: 'var(--ink)', display: 'inline-flex', justifyContent: 'center', width: '100%', maxWidth: 250 }}>Get Started <Icon.Arrow /></a>
      </div>
      <div style={{ marginTop: 80, paddingTop: 40, borderTop: '1px solid var(--line-soft)', fontSize: 14, color: 'var(--ink-3)' }}>
        <h3 className="serif" style={{ fontSize: 24, marginBottom: 24, color: 'var(--ink)' }}>References</h3>
        <ol style={{ paddingLeft: 20, display: 'flex', flexDirection: 'column', gap: 16 }}>
          <li>Arterburn, D. E., et al. (2020). Long-term outcomes after bariatric surgery. <em>JAMA</em>, 324(7), 674–683.</li>
          <li>Jastreboff, A. M., et al. (2022). Tirzepatide for obesity (SURMOUNT-1). <em>NEJM</em>, 387(3), 205–216.</li>
          <li>Lincoff, A. M., et al. (2023). Semaglutide and cardiovascular outcomes (SELECT). <em>NEJM</em>, 389(24), 2221–2232.</li>
        </ol>
      </div>
    </div>
  </div></section></>);
}
export { BlogBariatricVsGLP1 };
